Ahsanuddin Ahmad
Clinical Cardiac Electrophysiology · Jersey City, NJNPI 1962529388
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Boston Scientific at 50.6% of the total.
Across 288 payments — averaging $61.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$9K
- Medtronic$4K
- Biosense Webster, Inc.$2K
- Abbott$902
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$307
- Merck$279
- plus $1K from 19 others
What the payments were for
- Consulting fees$2251%
- Travel & lodging$7,64643%
- Food & beverage$9,74555%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 89 | $8,912 |
| Medtronic(2 entities) | 38 | $4,176 |
| Biosense Webster, Inc. | 60 | $1,664 |
| Abbott | 8 | $902 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $307 |
| Merck | 18 | $279 |
| E.r. Squibb & Sons, L.L.C. | 16 | $264 |
| Amgen | 6 | $198 |
| Pfizer | 10 | $153 |
| Edwards Lifesciences | 1 | $131 |
| Heartflow, Inc. | 2 | $102 |
| Johnson & Johnson | 6 | $89 |
| Atricure, Inc. | 2 | $65 |
| Cardiva Medical, Inc. | 2 | $54 |
| Novartis | 3 | $53 |
| Abiomed | 2 | $52 |
| Impulse Dynamics (USA) Inc. | 3 | $49 |
| Alnylam Pharmaceuticals Inc. | 2 | $37 |
| Boehringer Ingelheim | 2 | $31 |
| Cvrx, Inc. | 1 | $19 |
| Altathera Pharmaceuticals LLC | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Farapulse$2,973
- GENERAL - THERAPIES$1,427
- Watchman$1,213
- AVEIR$618
- COBALT DR MRI SURESCAN$302
- Viva$267
- AZURE XT DR MRI SURESCAN$206
- Micra$191
- CLARIA MRI QUAD CRT-D SURESCAN$160
- QUADRA ASSURA$145
- Claria MRI$128
- GENERAL TACHY$125
- Repatha$125
- Carto 3$124
- CoreValve Evolut$109
- Evera$103
How this compares
$17,616 in reported general payments places this provider in the 55th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 316 | $317,488 |
| EntrestoSacubitril/Valsartan | 61 | $70,286 |
| XareltoRivaroxaban | 52 | $50,549 |
| JardianceEmpagliflozin | 11 | $19,186 |
| Valsartan | 35 | $1,599 |
| Atorvastatin Calcium | 76 | $1,257 |
| Metoprolol Succinate | 68 | $1,207 |
| Flecainide Acetate | 15 | $747 |
| Dofetilide | 12 | $673 |
| Bisoprolol Fumarate | 11 | $509 |
| Amiodarone Hcl | 21 | $415 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 13 | $411 |
| Hydralazine Hcl | 15 | $356 |
| Carvedilol | 50 | $351 |
| Rosuvastatin Calcium | 21 | $334 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $153 | $317,488316 claims |
| NovartisEntresto | $53 | $70,28661 claims |
| Johnson & JohnsonXarelto | $89 | $50,54952 claims |
| Boehringer IngelheimJardiance | $31 | $19,18611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Jersey City
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Michael LinkGalloway$96K
- Grant SimonsEnglewood$93K
- Jonathan SteinbergRidgewood$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.